New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2014
09:49 EDTREGNRegeneron sees favorable tax impact from move into Ireland
Regeneron said during its Q4 earnings call earlier that the company is in the process of expanding its manufacturing capabilities into Ireland. "Over the long term with expansion of our international operations, we expect to achieve a tax efficient operating model," the company said, noting the establishment of the new manufacturing facility in Ireland as one step, along with the migration of certain intellectual property in its late stage antibody pipeline to Ireland. The company sees the steps allowing it to get "favorable" tax rates beginning in the 2017 year, it added.
News For REGN From The Last 14 Days
Check below for free stories on REGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2014
13:58 EDTREGNRegeneron expected to receive priority review at Piper Jaffray
Piper Jaffray expects Regeneron (REGN) and Sanofi (SNY) will receive priority review for alirocumab via the priority review voucher recently acquired from BioMarin (BMRN). Piper says potential approval of the drug is likely by mid-2015 and it reiterates an Overweight rating on Regeneron with a $382 price target.
13:48 EDTREGNRegeneron price target raised to $390 from $380 at Brean Capital
Subscribe for More Information
08:04 EDTREGNRegeneron price target raised to $436 from $389 at Leerink
Leerink raised its price target for Regeneron shares to $436 after its survey of 100 physicians indicated potential blockbuster status for the company's PCSK9-inhibitor Alirocumab. The firm reiterates an Outperform rating on the stock.
07:21 EDTREGNRegeneron data positive, says RBC Capital
Subscribe for More Information
07:14 EDTREGNRegeneron price target raised to $400 from $340 at Credit Suisse
Subscribe for More Information
August 31, 2014
14:22 EDTREGNSanofi, Regeneron announce results from four Phase 3 ODYSSEY trials
Subscribe for More Information
13:59 EDTREGNRW Baird to hold a conference
Subscribe for More Information
13:41 EDTREGNCitigroup to hold a conference
Subscribe for More Information
12:50 EDTREGNEuropean Society of Cardiology to hold a conference
Subscribe for More Information
August 29, 2014
12:23 EDTREGNNovartis drug data to be presented this weekend
Subscribe for More Information
August 25, 2014
11:48 EDTREGNSanofi and Regeneron co-host a conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use